Antonio Cancer team Finds new Approach for Triple Negative Breast Cancer
source: pixabay.com

Antonio Cancer team Finds new Approach for Triple Negative Breast Cancer

An antidepressant drug that was approved by the FDA in 1959 is being put to new and promising use to fight hard-to-treat breast cancers. The antidepressant, imipramine, was approved to…

Continue Reading Antonio Cancer team Finds new Approach for Triple Negative Breast Cancer
INTERVIEWS: NFL Players Discuss the Rare, Chronic, and Underserved Causes that Mean the Most to Them (Pt. 4)
Source: Pixabay

INTERVIEWS: NFL Players Discuss the Rare, Chronic, and Underserved Causes that Mean the Most to Them (Pt. 4)

Before you read on, make sure to check out: Part 1: Green Bay Packers' Shemar Jean-Charles and Los Angeles Chargers' Storm Norton talk about the importance of Alzheimer's disease awareness. …

Continue Reading INTERVIEWS: NFL Players Discuss the Rare, Chronic, and Underserved Causes that Mean the Most to Them (Pt. 4)
A Metastatic Breast Cancer Diagnosis at Age 24: Savanah’s Story (Pt. 1)
source: pixabay.com

A Metastatic Breast Cancer Diagnosis at Age 24: Savanah’s Story (Pt. 1)

October is Breast Cancer Awareness Month. This month is dedicated to raising awareness about the impact of breast cancer, raising funds for research, supporting those with breast cancer, and advocating…

Continue Reading A Metastatic Breast Cancer Diagnosis at Age 24: Savanah’s Story (Pt. 1)
Physical Fitness Improves Chemotherapy for Patients with Breast Cancer
https://pixabay.com/en/crossfit-sports-fitness-training-534615/

Physical Fitness Improves Chemotherapy for Patients with Breast Cancer

It’s no secret that physical fitness can, in many cases, improve our overall health and wellness. But could being physically fit also improve healthcare and treatment response? According to Medical…

Continue Reading Physical Fitness Improves Chemotherapy for Patients with Breast Cancer
LYNPARZA Trial for BRCA-Mutated HER2-Negative Breast Cancer Achieved iDFS Superiority Boundary
Source: Pixabay

LYNPARZA Trial for BRCA-Mutated HER2-Negative Breast Cancer Achieved iDFS Superiority Boundary

  In a joint statement, biopharmaceutical companies AstraZeneca and Merck & Co., Inc. ("Merck") shared that LYNPARZA (olaparib) achieved a superiority boundary in the Phase 3 OlympiA clinical trial. During…

Continue Reading LYNPARZA Trial for BRCA-Mutated HER2-Negative Breast Cancer Achieved iDFS Superiority Boundary